Fund Facts  

Inception Date: Aug 17, 1999
Ticker Symbol: VTMGX
Morningstar Category:Foreign Large Blend
As of Mar 31, 2016
Fund Net Assets ($millions) $56,241

Documents for Fund or Underlying Fund(s)  

Description

Objective  

The investment seeks to track the performance of the FTSE Developed All Cap ex US Transition Index.

Principal Investment Strategies  

The fund employs an indexing investment approach designed to track the performance of the FTSE Developed All Cap ex US Transition Index, an interim index that will gradually increase exposure to small-capitalization stocks and Canadian equities while proportionately reducing exposure to other stocks based on their weightings in the FTSE Developed All Cap ex US Index.

Principal Investment Risks  

There is no guarantee that the Fund will achieve its investment objective. You may lose money by investing in the Fund. Please see the Risk Glossary for additional information about the Fund’s risks.

 

Performance & Expenses

Standard Performance As of Mar 31, 2016
Fund/Benchmark Name QtrYTD1-Yr3-Yr5-Yr10-YrSince Inception
Vanguard Developed Markets Idxa-2.02%-2.02%-7.35%2.54%2.52%2.05%3.31%
FTSE Developed ex North America Index (Net)a,b-2.70%-2.70%-7.78%2.26%2.15%2.13%N/A
Morningstar Foreign Large Blenda,c-1.98%-1.98%-7.99%1.72%1.61%1.57%N/A

Fund past performance, as shown, is no guarantee of how the fund will perform in the future. The performance shown has been annualized for periods greater than one year. Investment returns and principal value will fluctuate, so that an investor's shares, when redeemed, may be worth more or less than their original cost. For current performance, visit www.icmarc.org.

Fund performance is shown comparing it to a "benchmark" which may be a (i) broad-based securities market index (ii) a group of mutual funds with similar investment objectives, or (iii) a short term government backed debt obligation such as a U.S. Treasury Bill. An index is not available for direct investment, is unmanaged, and does not reflect the costs of portfolio management or trading. A fund's portfolio may differ from the securities held in an index.

Annual Fund Operating Expenses
Total expensesa0.09%

 

a. Returns and/or expenses provided by Morningstar, Inc. Copyright © 2016. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. ICMA-RC does not independently verify Morningstar data.

b. The FTSE Developed ex North America Index (Net) is a market-capitalization weighted index representing the performance of around 1380 large and mid cap companies in 23 Developed markets, excluding the USA and Canada, and approximates the minimum possible dividend reinvestment after deduction of withholding tax according to FTSE's methodology.

c. The Morningstar Category Average is the equal-weighted average return of all funds per category, as identified by Morningstar, Inc.

Distributions

Dividends and Capital Gains  
Record Date Ex/Payable Date Income/Capital Gains Paid Per Share
Mar 14, 2016Mar 14, 2016$0.051000000
Dec 18, 2015Dec 18, 2015$0.070000000
Sep 24, 2015Sep 24, 2015$0.051000000
Jun 25, 2015Jun 25, 2015$0.165000000
Mar 24, 2015Mar 24, 2015$0.058000000
Dec 19, 2014Dec 19, 2014$0.077000000
Sep 23, 2014Sep 23, 2014$0.069000000
Jun 23, 2014Jun 23, 2014$0.165000000
Mar 24, 2014Mar 24, 2014$0.139000000
 

Morningstar Information

Morningstar Rating   As of Mar 31, 2016
Period Stars Category Size
Overall 3 Stars712
3-Year 3 Stars712
5-Year 4 Stars624
10-Year 3 Stars359

For each fund with at least a three-year history, Morningstar calculates a Morningstar Rating™ based on a Morningstar Risk-Adjusted Return measure that accounts for variation in a fund's monthly performance (including the effects of sales charges, loads, fee waivers, and redemption fees), placing more emphasis on downward variations and rewarding consistent performance. The top 10% of funds in each category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars and the bottom 10% receive 1 star. The Overall Morningstar Rating for a fund is derived from a weighted average of the performance figures associated with its three-, five- and ten-year (if applicable) Morningstar Rating metrics. For funds with loads, the Morningstar rating on a load-waived basis is provided, when available. Load-waived ratings do not include any front- or back-end sales loads and are intended for investors that have access to such purchase terms. Funds with loads are waived for plans administered by ICMA-RC. Past performance is no guarantee of future results.

Morningstar Stylebox As of Mar 31, 2016
Equity Stylebox
Large Blend
Allocation of Assets As of Feb 29, 2016
Type of Asset Percent
Equity97%
Fixed Income0%
Cash/Other3%

Due to rounding, percentages shown may not add up to 100%.

 
 

Characteristics

Allocation of Assets As of Feb 29, 2016
Asset ClassPercent
Domestic Stock0.5%
Foreign Stock96.9%
Domestic Bond0.0%
Foreign Bond0.0%
Preferred0.1%
Convertible0.0%
Cash1.3%
Other1.3%

Due to rounding, percentages shown may not add up to 100%.

 
Equity Sector As of Feb 29, 2016
SectorPercent
Financial Services18.4%
Industrials12.3%
Consumer Cyclical12.3%
Consumer Defensive11.8%
Healthcare10.6%
Basic Materials7.4%
Technology6.9%
Energy4.9%
Communication Services4.7%
Real Estate3.6%
Utilities3.2%

Exposure reflects equity securities only and will sum to the equity exposure of the fund.

 
Top Ten Country Exposure As of Feb 29, 2016
CountryPercent
Japan22.1%
United Kingdom17.5%
France8.3%
Switzerland7.9%
Germany7.8%
Australia6.0%
South Korea3.9%
Canada3.9%
Sweden2.6%
Spain2.6%
Top Ten Holdings As of Feb 29, 2016
Holding NamePercent
Nestle SA1.6%
Roche Holding AG Dividend Right Cert.1.4%
Novartis AG1.1%
Toyota Motor Corp1.1%
HSBC Holdings PLC0.9%
British American Tobacco PLC0.8%
Novo Nordisk A/S B0.7%
GlaxoSmithKline PLC0.7%
Total SA0.7%
Anheuser-Busch Inbev SA0.7%
 

Statistics

Portfolio Statistics As of Mar 31, 2016
Statistic3-Year5-Year
Beta0.960.96
Alpha2.202.20
Standard Deviation13.2915.37
 
 

Footnotes

1.

Please read the fund's prospectus carefully for a complete summary of all fees, expenses, investment objectives and strategies, risks, financial highlights, and performance information. Investing involves risk, including possible loss of the amount invested. Investors should carefully consider the information contained in the prospectus before investing. You may contact us to obtain a prospectus or to answer questions by calling 800-669-7400, emailing investorservices@icmarc.org, or visiting www.icmarc.org.

The source for this information is Morningstar, Inc. Copyright © 2016 Morningstar, Inc.® All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Morningstar, Inc. is a global investment research firm that is not affiliated with ICMA-RC. ICMA-RC does not independently verify Morningstar data.

Morningstar places funds in certain categories based on the fund's historical portfolio holdings. Placement of a fund in a particular Morningstar category does not mean that the fund will remain in that category or that it will invest primarily in securities consistent with its Morningstar category. A fund's investment strategy and portfolio holdings are governed by its prospectus, guidelines or other governing documents, not its Morningstar category.